FDA Approves Furoscix (furosemide) for Edema in Heart Failure and CKD
FDA approves new diuretic Furoscix for heart and kidney patients
The FDA approved Furoscix (furosemide) subcutaneous injection for edema in pediatric patients weighing 43 kg and above and in adults with ch…
The FDA approved Furoscix (furosemide) to treat fluid buildup in adults and children weighing 43 kg or more with chronic heart failure or ki…
FDA Approves Ziac (bisoprolol/hydrochlorothiazide) for Hypertension
FDA approves Ziac, a new combination pill for high blood pressure.
FDA approved Ziac (bisoprolol fumarate/hydrochlorothiazide) for the management of hypertension. The combination provides additive blood pres…
The FDA approved Ziac, a combination of two blood pressure medicines, for treating hypertension. It is for patients who need more than one d…
FDA Approves Avapro (irbesartan) for Hypertension and Diabetic Nephropathy
FDA approves Avapro to treat high blood pressure and kidney disease in diabetes.
FDA approved Avapro (irbesartan) for hypertension and for diabetic nephropathy in hypertensive type 2 diabetes patients with elevated creati…
The FDA approved Avapro (irbesartan) for high blood pressure and for kidney disease in people with type 2 diabetes. It helps lower blood pre…
Behavioral and metabolic factors characterize a distinct premature atherosclerosis phenotype in Chinese patients
Smoking and Metabolic Factors Linked to Heart Attacks in China
This systematic review of 317 observational studies maps risk factors for premature myocardial infarction (PMI) in China. The synthesis iden…
A large review of 317 studies identifies specific behavioral and metabolic risk factors for heart attacks among Chinese patients.
Novel pharmacotherapies like resmetirom and GLP-1 receptor agonists offer potential concurrent hepatic and cardiovascular benefits
New Medications Show Potential to Treat Liver and Heart Disease
This systematic review examines the epidemiological links and shared pathophysiological mechanisms between metabolic dysfunction-associated …
Newer drugs like resmetirom and GLP-1 receptor agonists may offer dual benefits for patients with both liver and heart conditions.
Ticagrelor reduces mortality and major adverse cardiovascular events compared to clopidogrel in STEMI patients
Ticagrelor Shows Lower Mortality Risk Than Clopidogrel for Heart Patients
This meta-analysis of 31,729 adult STEMI patients post-PCI found that ticagrelor significantly reduced all-cause mortality (OR = 0.64) and m…
A large analysis of over 31,000 patients suggests ticagrelor may lower mortality and heart attack risks compared to clopidogrel after a hear…
Antazoline May Beat Propafenone and Amiodarone for AF Conversion
Antazoline shows better results for atrial fibrillation heart rhythms
A meta-analysis suggests antazoline is more effective than propafenone or amiodarone for converting atrial fibrillation to sinus rhythm, wit…
A new review suggests antazoline may be more effective than common medications at restoring normal heart rhythms for patients with atrial fi…
Ferroptosis regulation via phytochemicals and targeted delivery systems offers potential to mitigate doxorubicin-induced cardiotoxicity
New strategies may protect heart during chemo without reducing cancer fight
This systematic review examines the mechanisms of myocardial ferroptosis during doxorubicin treatment and evaluates various intervention str…
A review reveals innovative ways to shield the heart from doxorubicin damage while keeping its cancer-killing power intact.
Traditional Chinese medicine bioactive constituents may improve endothelial function and reduce oxidative stress in atherosclerosis
Traditional Chinese Medicine May Help Manage Atherosclerosis Symptoms
This systematic review synthesizes the mechanisms by which Traditional Chinese medicine (TCM) and its bioactive components influence atheros…
New research suggests that Traditional Chinese medicine and its components may help improve blood vessel health and reduce inflammation in a…
Percutaneous transcatheter closure using an Amplatzer Muscular VSD Occluder treats left ventricular pseudoaneurysm
Transcatheter Closure Shows Promise for Heart Failure Patients
This case report describes a 75-year-old male with heart failure and a left ventricular pseudoaneurysm successfully treated via percutaneous…
A new procedure using a transcatheter occluder may offer a safe way to treat heart failure caused by a specific heart wall defect.
Remote cardiac rehabilitation supported by mHealth improves exercise capacity in patients with heart failure
Virtual cardiac rehab improves exercise capacity for heart failure patients
Researchers evaluated the impact of structured, remote, and hybrid cardiac rehabilitation programs compared to usual care or center-based mo…
Remote and hybrid heart rehabilitation programs using mobile health tools can improve walking distance and oxygen use in people with heart f…
Staged PCI reduces severe kidney injury risk after TAVR in aortic stenosis and CAD
Staged heart procedures may lower risk of severe kidney injury
This meta-analysis of 7,119 patients with aortic stenosis and coronary artery disease undergoing TAVR found that staged PCI did not signific…
A new look at heart surgery data suggests that spacing out certain procedures could protect kidneys from severe damage.